Synta second-quarter net loss increases to $9.1 million

[News]

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended June 30, 2010.

More... (http://www.news-medical.net/news/20100810/Synta-second-quarter-net-loss-increases-to-2491-million.aspx)